cis-3-Hexen-1yl 2-methylpent-2-en-1-oate
| Common Name: |
cis-3-Hexen-1yl 2-methylpent-2-en-1-oate |
| IUPAC Name: |
[(E)-hex-3-enyl] (Z)-2-methylpent-2-enoate |
| Molecular Formula: |
C12H20O2 |
| SMILES: |
CCC=CCCOC(=O)C(=CCC)C |
| Inchi: |
1S/C12H20O2/c1-4-6-7-8-10-14-12(13)11(3)9-5-2/h6-7,9H,4-5,8,10H2,1-3H3/b7-6+,11-9- |
| Inchi Key: |
RTISFZCHFHFOOK-FKTQTOOFSA-N |
| Cas No: |
76649-17-7 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
196.29 |
| Mass (g/mol) |
196.146 |
| Molar Refractivity |
60.13 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
7 |
| Rings |
|
| TPSA |
26.30 |
| Hetero Atoms |
2 |
| Heavy Atoms |
14 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
125.00 @ 25.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
0.01 |
| Vapor Density (Air =1) |
>1 |
| Fraction Csp3 |
0.58 |
| LogP |
3.242 |
| iLOGP |
3.42 |
| XLOGP3 |
3.52 |
| WLOGP |
3.24 |
| MLOGP |
2.95 |
| ESOL Log S |
-2.81 |
| ESOL Solubility (mg/ml) |
0.302 |
| ESOL Solubility (mol/l) |
0.002 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-3.76 |
| Ali Solubility (mg/ml) |
0.03 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.53 |
| Silicos-IT Solubility (mg/ml) |
0.57 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.00 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.998 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.448 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
